Sponsored Links
| Conclusion Of Study Supports Business Model In The Use Of L-Dex U400 For Treatment Of Lymphoedema |
 |
 |
 |
| Medical News - Lymphology and Lymphedema | |||
|
ImpediMed Limited (ASX:IPD) would like to bring to the attention of all shareholders the publication: "Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study", published on the 16th March 2009 in the online edition of the Journal of Clinical Oncology. Read more: Lymphology/Lymphedema News From Medical News Today
|